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We have investigated the release of protons from thrombin-stimulated platelets. Addition of thrombin to 
suspensions of washed platelets resulted in fast liberation of H+. In the presence of 0.1 mM amiloride, 
a potent inhibitor of the Na+/H+ transport system, the amount of protons liberated was decreased by 
about 50070, and was further reduced to about 15% by 1 mM amiloride. Similar inhibition of H+ release 
was observed after Na+ in the incubating medium had been replaced by choline. We conclude that one 
of the earliest events in thrombin-stimulated platelets consists of the activation of an Na+/H+ 
countertransport, which leads to an increase in intracellular pH. 
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1. INTRODUCTION 2. EXPERIMENTAL 
Stimulation of human platelets by thrombin 
leads to a rapid acidification of their environment 
[ 1,2]. Whereas part of this acidification is due to 
increased lactate formation in stimulated platelets, 
the major part of proton liberation cannot be ac- 
counted for by increased glycolytic activity and 
has, therefore, descriptively been addressed as a 
‘lactate-unrelated burst of proton liberation’ [2]. 
Recently, authors in [3] demonstrated rapid 
alkalinization of the platelet interior, by about 0.3 
pH units, following activation by thrombin. The 
diuretic drug amiloride, which is known to 
specifically inhibit Na+/H’ exchange systems [4], 
inhibits thrombin-stimulated platelet aggregation 
and release of granular contents [5]. Inhibitory ef- 
fects on platelet aggregation, similar to those with 
amiloride, have been observed after removal of ex- 
traplatelet Naf [6]. These reports led us to in- 
vestigate whether stimulation of platelets by 
thrombin might activate an Na+/H+ counter- 
transport system. 
Human platelet-rich plasma (PRP) was obtained 
from fresh, titrated blood by centrifugation (150 x 
g for 12 min) and adjusted to pH 6.5 by adding 
0.1 N HCl. Platelets were pelleted by centrifuga- 
tion of PRP (1500 x g for 20 min) and resuspend- 
ed in buffer (136 mM NaCl, 2.7 mM KCI, 
0.18 mM KH2P04, 5 mM glucose, 0.2 mM 
EDTA, pH 6.5) and washed twice in this medium. 
The pH of the platelet suspension was finally 
adjusted to pH 7.4 with 0.01 M KOH, and the 
platelet count to 5-8 x lO”/l. 
In a reaction vessel (volume, 0.7 ml; ther- 
mostatted at 37°C) platelets were stimulated with 
bovine thrombin (Sigma, Munchen) and changes 
in pH in the suspending buffer were monitored 
with an electrode (Ingold, Frankfurt/Main) while 
stirring the buffer. Using the buffer capacity of the 
incubation buffer [77 pmol . (1. pH)-‘1, the record- 
ed pH changes allowed us to calculate the total 
amount of H’ released from thrombin-stimulated 
platelets. 
In some experiments, amiloride (Merck, Sharp 
& Dohme, Munchen) was added to the suspension 
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and 30 min were allowed for equilibration of 
platelets with this drug. In other experiments, 
platelets were suspended in buffer in which NaCl 
had been replaced by equimolar concentrations of 
choline chloride. 
3. RESULTS AND DISCUSSION 
Fig.1 illustrates the release of protons from 
unactivated (control) and thrombin-stimulated 
human platelets as the increase in total H+ concen- 
tration in the suspending buffer, A[H+]. 
In the absence of thrombin, there is a spon- 
taneous H+ release from platelets, which probably 
reflects lactic acid formation in the resting platelet 
[2]. Addition of thrombin (2 units/ml, arrow) 
results, after a lag of about 5 s, in a distinct in- 
crease in proton liberation, the kinetics of which 
may be described by (at least) two phases: a fast 
phase, which decays after about 40 s, and a slower 
phase, which is still faster than the control release. 
These kinetics are in qualitative agreement with [2] 
where the slow phase was related to increased lactic 
acid formation of thrombin-stimulated platelets. 
The early, fast phase could, however, not be at- 
tributed to changes in lactic acid formation [2]. 
The remainder of the discussion will be concerned 
with this early, fast phase. 
The total proton release of the early phase, 
A[H+]P+B, was obtained by extrapolating the slow 
phase after thrombin stimulation to zero time (see 
fig.1). In the experiment of fig.1, A[H+]P+~ 
amounted to 8.75 pmol/l buffer. Using a mean 
Fig.1. Release of protons from human platelets as a 
function of time. (0) Control. (0) Thrombin activation 
at time zero (arrow). Platelet concentration, 5.6 x 
lO”/l. Temperature, 37’C. Proton release from 
platelets to buffer during the early, fast phase, 
A[H+]p+a, obtained by base-line extrapolation at t = 0. 
value for platelet volume of 8 x lo-l5 1 [7], and a 
platelet concentration of 5.6 x lO”/l, this proton 
release amounts to p[H+]p+g = 2.0 mmol/(l 
platelet) in this experiment. The average value ob- 
tained in 6 determinations was 1.9 mmol/(l 
platelet) (SE = 0.2). Using an average value for pH 
changes in platelet upon thrombin stimulation [3] 
of ApH = 0.15, an intracellular total buffer value 
of,& = d[H+]p+~/dpH = 13 mmol.(l.pH)-’ may 
be estimated. This buffer value would reflect non- 
bicarbonate buffering since HCOl was nearly ab- 
sent in our preparation. 
Secretion of H+ from stimulated platelets was 
further measured at various concentrations of 
amiloride, ranging from 10m5 to 10m3 mol/l. This 
compound has been shown to block Na+ transport 
systems in a variety of cells and tissues [4]. In fig.2, 
the early, fast release of protons from thrombin- 
stimulated platelets, expressed as percentage of 
control (no amiloride) is plotted against inhibitor 
concentration. There exists a dose-dependent in- 
hibition of proton release, 50% of the total in- 
hibitory effect being obtained with 10e4 M, and 
85% with 10e3 M amiloride. This suggests that H+ 
release is linked to Na+ transport, as might be ex- 
pected if Na+/H+ counter-transport provided the 
fast H+ release. 
To further test this hypothesis, we have repeated 
the experiments with platelets suspended in buffer 
in which most of the extracellular Na+ was re- 
Fig.2. Effect of amiloride on the early phase of proton- 
release from thrombin-stimulated platelets. Ordinate, 
amount of H+ released in the early phase, A[H+]p+a as 
% of control (absence of amiloride); abscissa, 
concentration of amiloride (logarithmic scale). 
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Table 1 
Effect of replacing Na+ on the early, fast release of 
protons from thrombin-stimulated platelets 
Wa+lo A[H+lp-B N 
(mmol/l) 
mmol/l platelet % of control 
136 1.8 + 0.3 100 4 
23 1.1 If: 0.2 59 4 
6 0.4 f 0.13 22 4 
Mean values t- SE; N, number of measurements 
placed by choline. Table 1 summarizes the results. 
The early, fast release of protons from thrombin- 
activated platelets is largely reduced when ex- 
tracellular Na+ concentration, [Na+lo, is lowered. 
With both amiloride and Na+-depletion, the slow, 
late phase of H+ release was retarded but not 
suppressed. 
Both results, inhibition of the early H+ release 
by amiloride or by decreased extracellular Na+, 
suggest that one of the earliest steps following 
thrombin stimulation of platelets consists of the 
activation of Na+/H+ exchange across the platelet 
plasma membrane with subsequent alkalinization 
of intracellular pH. 
Recent reports from the literature suggest hat 
other platelet-activating substances may exert their 
action via similar mechanisms. It has, thus, been 
shown that incubation of platelets with ADP, 
which constitutes a physiologically important 
platelet-aggregating substance, stimulates net up- 
take of Na+ into the activated cells [8,9]. Further- 
more, inhibition of the Na+ transport system by 
amiloride leads to a marked reduction of ADP- 
induced platelet shape change and cytoskeletal 
assembly [lo]. The physiological significance of 
this process, however, is still poorly understood. 
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